Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 15614, Iran.
Cells. 2023 Dec 26;13(1):50. doi: 10.3390/cells13010050.
Age-related macular degeneration (AMD) remains a leading cause of vision loss in elderly patients. Its etiology and progression are, however, deeply intertwined with various cellular and molecular interactions within the retina and choroid. Among the key cellular players least studied are choroidal mast cells, with important roles in immune and allergic responses. Here, we will review what is known regarding the pathophysiology of AMD and expand on the recently proposed intricate roles of choroidal mast cells and their activation in outer retinal degeneration and AMD pathogenesis. We will focus on choroidal mast cell activation, the release of their bioactive mediators, and potential impact on ocular oxidative stress, inflammation, and overall retinal and choroidal health. We propose an important role for thrombospondin-1 (TSP1), a major ocular angioinflammatory factor, in regulation of choroidal mast cell homeostasis and activation in AMD pathogenesis. Drawing from limited studies, this review underscores the need for further comprehensive studies aimed at understanding the precise roles changes in TSP1 levels and choroidal mast cell activity play in pathophysiology of AMD. We will also propose potential therapeutic strategies targeting these regulatory pathways, and highlighting the promise they hold for curbing AMD progression through modulation of mast cell activity. In conclusion, the evolving understanding of the role of choroidal mast cells in AMD pathogenesis will not only offer deeper insights into the underlying mechanisms but will also offer opportunities for development of novel preventive strategies.
年龄相关性黄斑变性(AMD)仍然是老年患者视力丧失的主要原因。然而,其病因和进展与视网膜和脉络膜内的各种细胞和分子相互作用密切相关。在研究最少的关键细胞中,有脉络膜肥大细胞,它们在免疫和过敏反应中起着重要作用。在这里,我们将回顾已知的 AMD 的病理生理学,并扩展最近提出的脉络膜肥大细胞及其在外层视网膜变性和 AMD 发病机制中的激活的复杂作用。我们将重点介绍脉络膜肥大细胞的激活、它们的生物活性介质的释放以及对眼部氧化应激、炎症和整体视网膜和脉络膜健康的潜在影响。我们提出,血小板反应蛋白 1(TSP1)在 AMD 发病机制中对调节脉络膜肥大细胞的稳态和激活具有重要作用,TSP1 是一种主要的眼部血管炎症因子。从有限的研究中可以看出,这篇综述强调了需要进一步进行全面研究,以了解 TSP1 水平和脉络膜肥大细胞活性变化在 AMD 病理生理学中的精确作用。我们还将提出针对这些调节途径的潜在治疗策略,并强调它们通过调节肥大细胞活性来抑制 AMD 进展的潜力。总之,对脉络膜肥大细胞在 AMD 发病机制中的作用的不断发展的认识不仅将提供对潜在机制的更深入了解,还将为开发新的预防策略提供机会。